Concepedia

Thomas P. C. Dorlo

TP

Statistics

Publications

57

Citations

2.5K

H-Index

27

Active since

2008

Affiliations

The Netherlands Cancer Institute(Current)

Utrecht University

University Medical Center Utrecht

Slotervaartziekenhuis

Drugs for Neglected Diseases Initiative

Thomas P. C. Dorlo is an author at The Netherlands Cancer Institute specializing in pharmacology, pharmacy, and treatment of leishmaniasis.

ORCID

Publications per year

2008–2024

57

Publications

57

Increasing Failure of Miltefosine in the Treatment of Kala-azar in Nepal and the Potential Role of Parasite Drug Resistance, Reinfection, or Noncompliance

Suman Rijal, Bart Ostyn, Surendra Uranw et al. · Clinical Infectious Diseases · 2013 · 316 citations · Full text

, , +17

Pharmacokinetics of Miltefosine in Old World Cutaneous Leishmaniasis Patients

Thomas P. C. Dorlo, P. P. A. M. van Thiel, Alwin D. R. Huitema et al. · Antimicrobial Agents and Chemotherapy · 2008 · 163 citations · Full text

, , +13

Failure of Miltefosine in Visceral Leishmaniasis Is Associated With Low Drug Exposure

Thomas P. C. Dorlo, Suman Rijal, Bart Ostyn et al. · The Journal of Infectious Diseases · 2014 · 129 citations · Full text

, , +16

Optimal Dosing of Miltefosine in Children and Adults with Visceral Leishmaniasis

Thomas P. C. Dorlo, Alwin D. R. Huitema, Jos H. Beijnen et al. · Antimicrobial Agents and Chemotherapy · 2012 · 105 citations · Full text

, , +16

Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized Trial

Monique Wasunna, Simon Njenga, Manica Balasegaram et al. · PLoS neglected tropical diseases · 2016 · 104 citations · Full text

, , +15

1–5 of 57